Drugs target to CD47

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
EVORPACEPTProteinovarian cancerLeukocyte surface antigen CD47 inhibitor2.0Not yet recruitingClinicalTrials
MAGROLIMABAntibodyclassic Hodgkin lymphomaLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
EVORPACEPTProteinnon-Hodgkins lymphomaLeukocyte surface antigen CD47 inhibitor1.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodyacute myeloid leukemiaLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials
MAGROLIMABAntibodyacute myeloid leukemiaLeukocyte surface antigen CD47 inhibitor1.0TerminatedClinicalTrials
MAGROLIMABAntibodybrain cancerLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodymetastatic colorectal cancerLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
MAGROLIMABAntibodymyelodysplastic syndromeLeukocyte surface antigen CD47 inhibitor3.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodyovarian cancerLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials
MAGROLIMABAntibodymultiple myelomaLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
MAGROLIMABAntibodyurinary bladder cancerLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodycolorectal carcinomaLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials
EVORPACEPTProteinacute myeloid leukemiaLeukocyte surface antigen CD47 inhibitor1.0Active, not recruitingClinicalTrials
EVORPACEPTProteinmetastatic colorectal cancerLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
EVORPACEPTProteincancerLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodyacute myeloid leukemiaLeukocyte surface antigen CD47 inhibitor3.0RecruitingClinicalTrials
MAGROLIMABAntibodytriple-negative breast cancerLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
EVORPACEPTProteinmyelodysplastic syndromeLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
EVORPACEPTProteinhead and neck squamous cell carcinomaLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
MAGROLIMABAntibodynon-Hodgkins lymphomaLeukocyte surface antigen CD47 inhibitor1.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodyneoplasmLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
EVORPACEPTProteinmetastatic malignant neoplasmLeukocyte surface antigen CD47 inhibitor1.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodydiffuse large B-cell lymphomaLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials
MAGROLIMABAntibodyneoplasmLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials
MAGROLIMABAntibodymycosis fungoidesLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodylymphoid neoplasmLeukocyte surface antigen CD47 inhibitor1.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodyurothelial carcinomaLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodySezary's diseaseLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodyacute myeloid leukemiaLeukocyte surface antigen CD47 inhibitor1.0RecruitingClinicalTrials
MAGROLIMABAntibodyhead and neck squamous cell carcinomaLeukocyte surface antigen CD47 inhibitor2.0RecruitingClinicalTrials
MAGROLIMABAntibodycancerLeukocyte surface antigen CD47 inhibitor2.0Active, not recruitingClinicalTrials
MAGROLIMABAntibodymyelodysplastic syndromeLeukocyte surface antigen CD47 inhibitor1.0CompletedClinicalTrials